Feasibility Study of Auditory Brainstem Implant in Young Children
NCT ID: NCT01850225
Last Updated: 2015-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1
INTERVENTIONAL
2013-10-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects
NCT01864291
An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
NCT00030043
Safety and Efficacy Study of HuCNS-SC in Subjects With Neuronal Ceroid Lipofuscinosis
NCT01238315
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
NCT01129687
AI Recognition of Important Structures in Otolaryngological Surgery
NCT06726551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Device implantation
Implantation of device
Auditory brainstem implant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auditory brainstem implant
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* If previously received a cochlear implant, must demonstrate lack of benefit from that device
Exclusion Criteria
* Severe cognitive or developmental delays
2 Years
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
House Clinic, Inc.
INDUSTRY
Children's Hospital Los Angeles
OTHER
House Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Wilkinson, MD
Role: PRINCIPAL_INVESTIGATOR
House Research Institute
Laurie Eisenberg, PhD
Role: PRINCIPAL_INVESTIGATOR
House Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
House Research Institute CARE Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ped ABI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.